The Solidarity Trial published interim results on 15 October 2020. It found that all 4 treatments evaluated (remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon) had little or no effect on overall mortality, initiation of ventilation and duration of hospital stay in hospitalized patients.
In fact, the mega trial, which also studied the effect of hydroxychloroquine, a combination of HIV drugs lopinavir and ritonavir, as well as a combination of lopinavir and interferon, showed that none of the drugs actually showed any effect, according to the study.
Despite failure many doctors are prescribing remdesivir and it is leading to black marketing of drug.
CoV A drug tout India Today TV investigated at Gurugram offered remdesivir, purportedly manufactured by Hetero, for Rs 20,000 a vial, almost six times its new MRP.
At Delhi’s Yusuf Sarai market, vendor Ravindra at the Helpline Medical Store agreed to supply remdesivir for around Rs 14,000 a vial. He claimed the product would be smuggled out of a hospital.
A 100-mg vial of the drug manufactured by Cadila now has a maximum retail price of Rs 899, Syngene’s Rs 2,450, Dr. Reddy’s Rs 2,700, Cipla’s Rs 3,000, Mylan’s Rs 3,400, Jubilant’s Rs 3,400, and Hetero’s Rs 3,490.
The UP government on Monday claimed there was no scarcity of Remdesivir injections in UP, and added that 25,000 vials of the anti-viral drug would reach the state by Tuesday evening.